China GrenTech Corporation Limited (NASDAQ: GRRF, “GrenTech,” or the “Company”), a leading China-based provider of radio frequency and wireless coverage products and services, today announced that it has entered into an amended and restated agreement and plan of merger with Talenthome Management Limited (”Parent”) and Xing Sheng Corporation Limited (”Merger Sub”) in order to amend certain provisions of the agreement and plan of merger among the parties entered into on January 12, 2012 (the “Original Merger Agreement,” and as amended and restated, the “Merger Agreement”). Merger Sub is a wholly-owned subsidiary of Parent which is jointly owned indirectly by Mr. Yingjie Gao, the Company’s Chairman and Chief Executive Officer (”Mr. Gao”), Ms. Rong Yu, the Company’s Director and Chief Financial Officer, and Ms. Yin Huang (together, the “Buyer Group”).

The amendments are being made to correct the inadvertent omission by the Company of 28,000,000 outstanding ordinary shares of the Company (the “Additional Shares”) from the total number of issued and outstanding shares initially stated in the Original Merger Agreement. The amended number of total issued and outstanding shares stated in the Merger Agreement is 587,397,825 ordinary shares. In addition to the expected proceeds from the previously announced loan commitment in the amount of HK$320,000,000 from Guotai Junan Finance (Hong Kong) Limited which the Buyer Group intends to use to finance the merger and other transactions contemplated by the Merger Agreement, Mr. Gao has committed to unconditionally disburse US$3.45 million to Parent by way of a shareholder loan at the effective time of the merger pursuant to a promissory note executed and delivered on January 20, 2012 in favor of Parent to provide funds for the acquisition of the Additional Shares in the event the merger is approved by the Company’s shareholders and the other closing conditions are satisfied. Mr. Gao’s disbursement obligation under the promissory note is guaranteed by Guoren Industrial Developments Limited, a shareholder of the Company which is wholly owned by Mr. Gao. Except as provided above, the material terms and conditions of the Original Merger Agreement, including the merger consideration of US$0.126 per ordinary share and US$3.15 per American depositary shares, remain unchanged. The Company’s Board of Directors, acting upon the unanimous recommendation of the Independent Committee formed by the Board of Directors, has approved the foregoing amendment and restatement of the Original Merger Agreement. Taking into account the Additional Shares, the Buyer Group collectively beneficially owns approximately 40.1% of the Company’s issued and outstanding ordinary shares.

About China GrenTech

GrenTech is a leading developer of radio frequency (”RF”) technology in China and a leading provider of wireless coverage products and services in China. The Company uses RF technology to design and manufacture wireless coverage products, which enables telecommunications operators to expand the reach of their wireless communication networks to indoor and outdoor areas such as buildings, highways, subways, tunnels and remote regions. China GrenTech’s wireless coverage services include design, installation and project warranty services. The Company also tailors the design and configuration of its wireless coverage products to the specific requirements of its customers.

Based on its in-house RF technology platform, the Company also develops and produces base station RF parts and components sold to base station manufacturers. GrenTech is a qualified supplier of RF parts and components to major global and domestic base station manufacturers.  For more information, please visit www.GrenTech.com.cn.

Safe Harbor Statement

Certain statements contained in this announcement may be viewed as “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995.  Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual performance, financial condition or results of operations of GrenTech to be materially different from any future performance, financial condition or results of operations implied by such forward-looking statements. The accuracy of these statements may be impacted by a number of business risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, and other risks outlined in GrenTech’s filings with the U.S. Securities and Exchange Commission, including its registration statement on Form F-1 and annual reports on Form 20-F. GrenTech undertakes no ongoing obligation, other than that imposed by law, to update these statements.

Popularity: 1% [?]

China Health Resource, Inc. (OTCBB: CHRI), announced today that the company has signed a 3 year exclusive agreement with a leading producer of Gastrodia in Pingwu, Sichuan.  This exclusive contract term is from April 1, 2012 to March 31, 2015, and extends the very successful product line for an additional 3 years from the prior agreement which will end March 31, 2012.  The quality of Gastrodia under this agreement is expected to comply to the latest formal TCM pharmaceutical standard and will give CHRI continued leverage in the Traditional Chinese Medicine (TCM) marketplace in China, as the main controlling distributor and supplier of pharmaceutical grade Gastrodia (also known as Tianma).

Widely recognized for producing high-quality Angelica, CHRI is expanding its TCM offerings with a highly regarded and marketable TCM herb, commonly known as Tianma in China. Pure Gastrodia in Pingwu County of the Sichuan Province contains a high content of active ingredients, with low heavy metal content. Free of pollution and boasting high quality, the demand in the market for pure Gastrodia surpasses the supply in Pingwu County.

“This exclusive agreement adds a stable high quality source of supply of our new flagship product, Gastrodia. Gastrodia demand is large and supply of pure Gastrodia of consistent quality is hard to find.  Having established our leading position in pharmaceutical Dahurian Angelica Root (DAR), allows us to attract high quality supply of key herbs which used with our standards can command higher prices for CHRI as well as our suppliers.” stated Jiayin Wang, Chairman and CEO of CHRI.

The company already started its General Agricultural Process (GAP) standard implementation for Gastrodia.  With standards in place, the quality can be properly managed and controlled.  This is considered by many experts as an essential step in the modernization of Traditional Chinese Medicine (TCM) products.

“CHRI is committed to establishing and promoting standards of raw herbs and TCM products. GAP DAR is now well accepted as the standard for pharmaceutical grade DAR in China and providing stable revenues and margins to CHRI. Gastrodia commands a larger market with high margins.  Gastrodia in 2011 has grown its sales in double-digits.  We expect the Gastrodia product line to continue to add significant revenue and earnings for many years.” added Jiayin Wang.

Gastrodia has large demand in China and Asia and further potential with the demands created from new alternative health products worldwide, general growing aging population and the imminent need to find alternative health solution with less side effects. Gastrodia currently retails for about 250~1,000 Yuan/kg (US$38~150/kg). It is considered one of China’s highest priced TCM drugs available in the market.

About CHRI

China Health Resource, Inc. engages in the development, manufacturing, processing, marketing and sale of raw and pharmaceutical TCM products including Dahurian Angelica Root (DAR) and Rhizoma Gastrodiae and is only the provider of GAP quality DAR in the People’s Republic of China under the registered Trademark Chuan Baizhi™. DAR, which is also known as “Bai Zhi” in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics and food, as well as used in TCM for the treatment of pain, swelling and pustule. The Company’s DAR-related products include the Bailing Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant Bag, all of which are sold through regional distributors. The Company was founded in 2001 and is based in Suining, Sichuan Province.

Certain statements in this document regarding financial matters, other than historical facts, and statements of our expectations, intentions, plans and beliefs, constitute “forward-looking statements” within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to certain events, risks and uncertainties that may be outside our control. The words “believe”, “expect”, “anticipate”, “optimistic”, “intend”, “will”, and similar expressions identify forward-looking statements. The company intends that such proclamations about future expectations, including future revenues and earnings, future business expansion plans, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company’s actual results may differ materially from expected results. These and other risks and uncertainties related to our business are described in greater detail in our filings with the Commission. The foregoing information should be read in conjunction with these filings. We disclaim any intention or obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.

Popularity: 1% [?]

China Shen Zhou Mining & Resources, Inc. (NYSE AMEX: SHZ), (”China Shen Zhou” or the “Company”), a Company engaged in the exploration, development, mining and processing of fluorite, zinc, lead, copper, and other nonferrous metals in China, today announced that the Company signed a Memorandum of Understanding to merge and acquire a number of fluorite and barite mining and mineral processing companies located in the Wuling mountains in the province of Guizhou. Negotiations are expected to be finalized within the next 60 days.

Since 2010, the Chinese government has issued a number of policies designed to raise the barriers to entry for the fluorite mining industry and to encourage fluorite mining companies to merge and integrate. China Shen Zhou, as the largest fluorite mining and mineral processing company in northern China, views the acquisition and integration of high-quality fluorite resources as a key part of the Company’s strategic plan.

Since the Company acquired 55% of Xinyi Mining Company in Anhui province, China Shen Zhou has considered acquiring a number of fluorite and barite rich mining companies located in southwestern China. As a result, China Shen Zhou identified and finished its due diligence on several targeted companies and the parties have reached an initial agreement regarding purchase price and transaction structure. Additional details concerning the acquisitions will be disclosed once the definitive agreements are executed.

Ms. Xiaojing Yu, the CEO of the China Shen Zhou, commented: “The Company has always believed that fluorite, as a widely used yet scarce strategic resource, will be in high demand given continuing economic development in China. China’s Wuling mountains are very rich in resources of fluorite and barite and possess excellent ore quality with low levels of phosphorus and sulfur. Barite is similar to fluorite as it is also a widely used diminishing resource.

“Because of China Shen Zhou’s advanced knowledge of the methods of separation of fluorite and barite ore and of methods of deep-processing of barite, the acquisitions of the Wuling mountain fluorite and barite resources will greatly enhance the Company’s reserves, laying the foundation for China Shen Zhou to become one of the largest fluorite mining and processing companies in China. Meanwhile, we will use the acquired barite resources to greatly improve the Company’s mining, processing and production capabilities.

“Furthermore, China Shen Zhou plans to work with local governments as well as both upstream and downstream enterprises to build a high-quality processing center and chemical industrial base to produce low-phosphorus and low-sulfur fluorite.”

Barite

Barite is a mineral consisting of barium sulfate, with a chemical composition of BaSO4, and is the largest natural mineral containing barium. Also, it is the largest source of barium. China is rich in barite, with barite reserves and production ranked the first in the world. Barite mines in China are mostly located in Guizhou province, which contains 34% of the total barite reserves in China.

Barite powder, the primary product of barite, is mainly used in the oil and gas industry as a weighting agent. Deep-processed precipitated barium sulfate, the raw material for making barium salts, is widely used in coatings, paints, inks, daily chemical products, textiles, papers and other products. Barite is categorized as a protective, non-metallic mining mineral by the Chinese Ministry of Land.

About China Shen Zhou Mining & Resources, Inc.

China Shen Zhou Mining & Resources, Inc., through its subsidiaries, is engaged in the exploration, development, mining, and processing of fluorite and nonferrous metals such as zinc, lead and copper in China. The Company has the following principal areas of interest in China: (a) fluorite extraction and processing in the Sumochaganaobao region of Inner Mongolia; (b) fluorite extraction and processing in Jingde County, Anhui Province; (c) zinc/copper/lead processing in Wulatehouqi of Inner Mongolia; and (d) zinc/copper exploration, mining and processing in Xinjiang.

For more information, please visit http://www.chinaszmg.com/.

Safe Harbor Statement

This press release may include certain statements that are not descriptions of historical facts, but are forward-looking statements. Forward-looking statements can be identified by the use of forward-looking terminology such as “will”, “believes”, “expects” or similar expressions. These forward-looking statements may also include statements about our proposed discussions related to our business or growth strategy, which is subject to change. Such information is based upon expectations of our management that were reasonable when made but may prove to be incorrect. All of such assumptions are inherently subject to uncertainties and contingencies beyond our control and upon assumptions with respect to future business decisions, which are subject to change. We do not undertake to update the forward-looking statements contained in this press release. For a description of the risks and uncertainties that may cause actual results to differ from the forward-looking statements contained in this press release, see our most recent Annual Report filed with the Securities and Exchange Commission (SEC) on Form 10-K, and our subsequent SEC filings. Copies of filings made with the SEC are available through the SEC’s electronic data gathering analysis retrieval system (EDGAR) at http://www.sec.gov.

Popularity: 1% [?]

China Nutrifruit Group Limited (NYSE Amex: CNGL) (”China Nutrifruit” or “the Company”), a leading producer of premium specialty fruit based products in China (”PRC”), today announced that the Company is conducting independent laboratory tests on its concentrate juice and glazed fruit products in response to a customer’s concern over product quality.

In December 2011, the Company was informed by its customer that China Nutrifruit’s concentrate juice and glazed fruit products contain higher than specified levels of sodium. The Company’s customer has requested China Nutrifruit for a full refund of the purchased products valued at approximately RMB50 million ($7.9 million). In response to this matter, the Company is currently performing independent laboratory tests to verify the product quality claims of its customer. As a precautionary measure, the Company has also implemented additional testing measures in its manufacturing process to ensure product quality.

Mr. Changjun Yu, Chairman of China Nutrifruit commented “Our business goal is to deliver healthy and nutritional fruit based products to our consumers and we will take every measure to ensure that. This is the only case of quality issue that has come to our attention. We are treating this matter very seriously and will carry out a thorough investigation. We are committed to stringent food quality control and safety standards. We have immediately set up a special investigation team to verify the claims of our customer and are prepared to take corrective measures, if required. We will announce the results of the laboratory tests as soon as the information is available. However, if verified, we are prepared to coordinate a voluntary recall and refund to our customer. This may have a negative impact to our financial and operation this year, nonetheless, our business operation remains normal as of today.”

China Nutrifruit’s manufacturing facilities are ISO9001 certified and meet the HACCP (Hazard Analysis & Critical Control Point) series qualifications.

About China Nutrifruit Group Limited

Through its subsidiaries Daqing Longheda Food Company Limited and Daqing Senyang Fruit and Vegetable Food Technology Company Limited, China Nutrifruit, is engaged in developing, processing, marketing and distributing a variety of food products processed primarily from premium specialty fruits grown in Northeast China, including golden berry, crab apple, blueberry, seabuckthorn, blackcurrant and raspberry. Its processing facility possesses ISO9001 and HACCP series qualifications. Currently, the Company has established an extensive nationwide sales and distribution network throughout 18 provinces in China. For more information, please visit http://www.chinanutrifruit.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”"). Such statements include, among others, those concerning our expected financial performance in fiscal year 2012, new products, our new facility, our estimates about sodium levels, and its expected impact on the Company’s business and financial performance, our expectations regarding the market for our existing products and new products, our expected financial performance and strategic and operational plans, as well as all assumptions, expectations, predictions, intentions or beliefs about future events. You are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results of the Company to differ materially from those anticipated, expressed or implied in the forward-looking statements. The words “believe,” “expect,” “anticipate,” “project,” “targets,” “optimistic,” “intend,” “aim,” “will” or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those anticipated include risks related to new and existing products; any projections of sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements regarding future economic conditions or performance; uncertainties related to conducting business in China; any statements of belief or intention; any of the factors mentioned in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended March 31, 2011, and other risks and uncertainties mentioned in our other reports filed with the Securities and Exchange Commission. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.

Popularity: 1% [?]